Hasibeder, A.; Pruefer, S.; Ebner, K. et al.
ADAMTS-13 REGULATES NEUTROPHIL RECRUITMENT IN A MOUSE MODEL OF INVASIVE PULMONARY ASPERGILLOSISHAEMATOLOGICA. Bd. 102. 2017 S. 257-257
Echchannaoui, Hakim; Dietrich, Karin; Theobald, Matthias
Adoptive immune transfer and CAR T-cells in malignant diseasesONKOLOGE. Bd. 23. H. 10. 2017 S. 815-822
Onida, Francesco; de Wreede, Liesbeth C.; van Biezen, Anja et al.
Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationBRITISH JOURNAL OF HAEMATOLOGY. Bd. 177. H. 5. 2017 S. 759-765
Jewell, Roxanne C.; Kipps, Thomas J.; Duerig, Jan et al.
Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapyLEUKEMIA & LYMPHOMA. Bd. 58. H. 2. 2017 S. 348-356
van Gelder, Michel; Ziagkos, Dimitris; de Wreede, Liesbeth et al.
Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMTCLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Bd. 17. H. 10. 2017 S. 667-+
Schreiber, J.; Korn, S.
Biologicals in severe asthma. Which antibody is for who?PNEUMOLOGE. Bd. 14. H. 5. 2017 S. 296-302
Krug, Norbert; Hohlfeld, Jens M.; Buhl, Roland et al.
Blood eosinophils predict therapeutic effects of a GATA3-specific DNAzyme in asthma patientsJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 140. H. 2. 2017 S. 625-+
Weber, Alexander N. R.; Bittner, Zsofia; Liu, Xiao et al.
Bruton's Tyrosine Kinase: An Emerging Key Player in Innate ImmunityFRONTIERS IN IMMUNOLOGY. Bd. 8. 2017
Bousquet, Jean; Brusselle, Guy; Buhl, Roland et al.
Care pathways for the selection of a biologic in severe asthmaEUROPEAN RESPIRATORY JOURNAL. Bd. 50. H. 6. 2017
Fischer, Jeannette; Paret, Claudia; El Malki, Khalifa et al.
CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial DiagnosisJOURNAL OF IMMUNOTHERAPY. Bd. 40. H. 5. 2017 S. 187-195